T. Rowe Price Associates’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27B | Sell |
|
|||||
|
2025
Q1 | $1.02B | Buy |
|
|||||
|
2024
Q4 | $900M | Sell |
|
|||||
|
2024
Q3 | $1.24B | Sell |
|
|||||
|
2024
Q2 | $1.07B | Buy |
|
|||||
|
2024
Q1 | $832M | Buy |
|
|||||
|
2023
Q4 | $538M | Buy |
|
|||||
|
2023
Q3 | $350M | Buy |
|
|||||
|
2023
Q2 | $6.07M | Buy |
|
|||||
|
2023
Q1 | $3.15M | Buy |
|
|||||
|
2022
Q4 | $2.55M | Buy |
|
|||||
|
2022
Q3 | $2.64M | Buy |
|
|||||
|
2022
Q2 | $2.67M | Sell |
|
|||||
|
2022
Q1 | $4.61M | Buy |
|
|||||
|
2021
Q4 | $4.21M | Sell |
|
|||||
|
2021
Q3 | $3.54M | Sell |
|
|||||
|
2021
Q2 | $3.9M | Sell |
|
|||||
|
2021
Q1 | $3.06M | Sell |
|
|||||
|
2020
Q4 | $2.44M | Sell |
|
|||||
|
2020
Q3 | $1.65M | Buy |
|
|||||
|
2020
Q2 | $1.21M | Buy |
|
|||||
|
2020
Q1 | $949K | Buy |
|
|||||
|
2019
Q4 | $2.11M | Buy |
|
|||||
|
2019
Q3 | $1.14M | Buy |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|
|||||
|
2019
Q1 | $1.33M | Sell |
|
|||||
|
2018
Q4 | $830K | Buy |
|
|||||
|
2018
Q3 | $1.06M | Buy |
|
|||||
|
2018
Q2 | $1.02M | Buy |
|
|||||
|
2018
Q1 | $603K | Buy |
|
|||||
|
2017
Q4 | $374K | Sell |
|
|||||
|
2017
Q3 | $718K | Hold |
|
|||||
|
2017
Q2 | $845K | Buy |
|
|||||
|
2017
Q1 | $773K | Buy |
|
|||||
|
2016
Q4 | $648K | Buy |
|
|||||
|
2016
Q3 | $880K | Buy |
|
|||||
|
2016
Q2 | $786K | Sell |
|
|||||
|
2016
Q1 | $5.24M | Sell |
|
|||||
|
2015
Q4 | $37.1M | Sell |
|
|||||
|
2015
Q3 | $58.4M | Sell |
|
|||||
|
2015
Q2 | $92.4M | Sell |
|
|||||
|
2015
Q1 | $103M | Buy |
|
|||||
|
2014
Q4 | $101M | Buy |
|
|||||
|
2014
Q3 | $117M | Sell |
|
|||||
|
2014
Q2 | $92.5M | Sell |
|
|||||
|
2014
Q1 | $84.6M | Buy |
|
|||||
|
2013
Q4 | $72.6M | Sell |
|
|||||
|
2013
Q3 | $86.3M | Buy |
|
|||||
|
2013
Q2 | $95.6M | Buy |
|